Invention Grant
- Patent Title: Allogeneic cellular immunotherapy for opportunistic infection
-
Application No.: US14500395Application Date: 2014-09-29
-
Publication No.: US10548956B2Publication Date: 2020-02-04
- Inventor: Michael Har-Noy
- Applicant: Immunovative Therapies, Ltd.
- Applicant Address: IL Jerusalem
- Assignee: MIRROR BIOLOGICS, INC.
- Current Assignee: MIRROR BIOLOGICS, INC.
- Current Assignee Address: IL Jerusalem
- Agency: Westman, Champlin & Koehler, P.A.
- Agent Z. Peter Sawicki; Visala Goswitz
- Main IPC: A61K39/00
- IPC: A61K39/00
Abstract:
A method for stimulating the immune system in immunocompromised patients in order to treat opportunistic infection. The method involves the infusion of intentionally mismatched allogeneic cells. In order to prevent graft vs. host disease complications, the allogeneic cells can be irradiated prior to infusion.
Public/Granted literature
- US20150024006A1 Allogeneic cellular immunotherapy for opportunistic infection Public/Granted day:2015-01-22
Information query
